UroTron™
In 2018, we introduced our urology range under the division UroTron™, marking our first major expansion. This division focuses on addressing various urological conditions with a portfolio of innovative products designed to improve patient outcomes.
| S. No. | Brand Name | Therapy |
|---|---|---|
| 1 | Hakosil-8 | BPH |
| 2 | Hakosil-D-8 | BPH |
| 3 | Hakotam-0.4 | BPH |
| 4 | Hakotam-D | BPH |
| 5 | Zosialfa | BPH |
| 6 | Zosialfa-D | BPH |
| 7 | Tavedro-A | Pain Management |
| 8 | Culiston-B6 | Calculi |
| 9 | Sodicitra | Calculi/UTI |
| 10 | Utibiotic | UTI |
| 11 | Utiriga Advance | UTI |
| 12 | Niftura | UTI |
| 13 | Usinacin | OAB |
| 14 | Usimira | OAB |
| 15 | Usimira-S | OAB |
| 16 | DarOABs | OAB |
| 17 | Bethvoid | OAB |
| 18 | Qliga | OATS |
| 19 | Tadnor-5 | BPH/ED |
| 20 | Tadnor-10 | ED |
| 21 | Ejadelay | PE |
| 22 | Tadplus | ED+PE |
| 23 | Enshrink | Uro-Oncology |
| 24 | Ytibira | Uro-Oncology |
| 25 | Bishrink | Uro-Oncology |
| 26 | Prostagonist | Uro-Oncology |
| 27 | Relantagonist | Uro-Oncology |